Skip to content

A Prospective Single-center Observational study on the Efficacy and Safety of the Endo GIA Tri-Staple in patients with Pulmonary Resection

A Prospective Single-center Observational study on the Efficacy and Safety of the Endo GIA Tri-Staple in patients with Pulmonary Resection - A Prospective Single-center Observational study on the Efficacy and Safety of the Endo GIA Tri-Staple in patients with Pulmonary Resection

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000006462
Enrollment
59
Registered
2011-10-05
Start date
2011-10-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Benign or malignant pulmonary lesions

Interventions

Sponsors

Kanagawa Cancer Center Department of Thoracic Surgery
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Pulmonary resection (excluding pneumonectomy) using surgical stapler is scheduled (regardless of cancer or non-cancer). 2) 20 years old or older (no upper limit) 3) No past history of ipsilateral thoracotomy 4) No past history of radiation therapy in the chest 5) No past history of chemotherapy with anticancer agent/s 6) Eastern Cooperative Oncology Group Scale of Performance Status (ECOG PS) of either 0 or 1 7) Written informed consent is obtained from the patient him/herself.

Exclusion criteria

Exclusion criteria: 1) Patients who are scheduled for a lobectomy and who are found to have a complete interlobar fissure when the chest is opened (surgical stapler is not needed for interlobar separation) 2) Patients in which factors predicting non-curable resection for lung cancer, such as pleural dissemination and malignant pleural effusion, are observed when the chest is opened 3) Patients who are complicated by active infection that requires treatment other than external medicine 4) Patients who continue on systemic steroid preparation (oral or intravenous) until the day of the operation 5) Patients who are complicated by poorly controlled diabetes mellitus (HbA1C>8.0) 6) Functions of the main organs are not maintained (Common terminology criteria for adverse events (CTCAE) ver. 4.0 Grade>=2). 7) Patients with malignant pleural effusion or cardiac effusion 8) Patients who are complicated by psychiatric disorders or psychiatric symptoms and who are judged to have difficulties in participating in the study 9) Other patients who are considered by the investigator or sub-investigator as not suitable for participation in this study

Design outcomes

Primary

MeasureTime frame
Incidence of prolomged air leaks (pulmonary fistula) that continue for more than five postoperative days

Secondary

MeasureTime frame
Incidence of air leaks occurring in the cut end during operation, incidence and degree of damage to the pleura, staple formation, haemostatic effect on the staple line, presence or absence of additional suture, whether or not sealing technique is applied and applied procedure, incidence of perioperative and postoperative adverse events, duration of placement of drain, duration of hospitalization (days)

Countries

Japan

Contacts

Public ContactMasahiro Tsuboi

Kanagawa Cancer Center Department of Thoracic Surgery

045-391-5761

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026